Opioid-Induced Constipation (OIC) Treatment Market

Opioid-Induced
Constipation (OIC)
Treatment Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
sales@futuremarketinsights.com
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: hari.t@futuremarketinsights.com




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Opioids are a class of medications that are regularly endorsed for their pain relieving, or
pain-killing, properties it is chronic and non-cancer pain. A typical symptom connected
with the utilization of these medications are that they decrease the gastrointestinal
tract's motility, making solid discharges and making patients strain. In addition, prolonged
utilization of opioids can prompt the harm of sensory system that causes body cells to
quit creating endogenous opioids, for example, endorphins. There is high risk of
constipation in adults since they have poor diet, poor fluid intake and immobility. The
typical symptoms for opioid-induced constipation are feeling lethargic, hard and dry
stools, distention and bulged abdomen, painful defecation and loss of appetite. The
opioid-induced constipation (OIC) treatment market is an exceptionally alluring and
promising market because of the expanding base of opioid-induced constipation OIC
sufferers.
Opioid-Induced Constipation (OIC) Treatment Market: Drivers and Restraints
Raising base of the illegal medication users and delayed utilization of opioids in the
treatment of chronic pain are the essential elements energizing the development of the
opioid- induced constipation (OIC) treatment business sector. In addition, expanded
mindfulness among patients and doctors for utilizing non-purgative medicine choices to
treat opioid induced constipation would promote drive the development of the OIC
treatment market sooner rather than later. In addition, it has been assessed that the
undiscovered market for successful, advantageous and safe medication treatment in OIC
drug is profoundly broad and developing.
Report
Description
Report Description
However, lack of awareness about opioid-induced constipation in patients, absence of
mindfulness with respect to the forthcoming treatment innovation, high costs of novel
pharmaceuticals and unfavorable reimbursement guidelines by medical coverage
organizations are probably the most prevailing limit for the opioid- induced constipation
treatment market.
Request free sample Report:
http://www.futuremarketinsights.com/reports/sample/rep-gb-1245
Opioid-Induced Constipation (OIC) Treatment Market: Overview
With expanding base of opioid-induced constipation (OIC) sufferers, the opioid-induced
constipation (OIC) treatment market is expected to have tremendous growth during the
forecast period (2016-2026). The latest trend in the opioid-induced constipation market
is development of novel and effective treatment technology by incurring nominal
expenses in research and development (R&D). Introducing convenient dosing,
peripherally restricted μ-opioid receptor antagonist (PAMORA) target main cause of
opioid- induced constipation (OIC) thiswill drive the opioid- induced constipation (OIC)
treatment market.
Opioid-Induced Constipation (OIC) Treatment Market: Segmentation
Report
Description
Report Description
Globalopioid-induced constipation (OIC)marketis segmented on the basis of active
ingredients, administration of drugs, drug class, distribution channel and geography as
following:
Segmentation by Active Ingredients
Naloxegol
Lubiprostone
Methylnaltrexone Bromide
Docusate Sodium
Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant
cathartics, Prostaglandins or prokinetic drugs)
Segmentation by method of administration
Oral
Parenteral (Subcutaneous Injection)
Segmentation by drug class
Peripherally-Restricted μ-opioid Receptor Antagonist (PAMORA)
Non-selective opioid antagonist
Report
Description
Report Description
μ-Opioid antagonist
Locally Acting Chloride Channel Activator (LACCA)
Segmentation by Distribution Channel
Drug store
Independent Pharmacies
Hospital Pharmacies
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1245
Opioid-Induced Constipation (OIC) Treatment Market: Region- wise Outlook
North America is the main market for opioid induced constipation treatment because of
the expanding base of OIC sufferers and illegal medication users. It is then followed by
Europe because of high incidence of opioid-induced constipation OIC for chronic pain.
Besides that, Latin America and South East-Asia area are some of potential areas where
presentation of successful opioid-induced constipation treatments may help up the
general income of a specific pharmaceutical organization, because of the expanding base
of OIC sufferers.
Report
Description
Report Description
The high development of the opioid-induced constipation market is credited to the
strong government motivation in healthcare sector likewise with the vicinity of an
extensive pool of patients suffering from chronic pain
Browse full report: http://www.futuremarketinsights.com/reports/opioid-Inducedconstipation-oic-treatment-market
Opioid-Induced Constipation (OIC) Treatment Market: Key Players
Key Players operating in this segment are GlaxoSmithKline, Inc., AstraZeneca plc, Inc.,
Pfizer, Inc., S.L.A. Pharma AG, AIKO Biotechnology, Cubist Pharmaceuticals, Salix
Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705